BCR-ABL kinase domain mutations, including 2 novel mutations in imatinib resistant Malaysian chronic myeloid leukemia patients-Frequency and clinical outcome. [electronic resource]
Producer: 20140602Description: 454-9 p. digitalISSN:- 1873-5835
- Adolescent
- Adult
- Aged
- Asian People -- genetics
- Benzamides -- therapeutic use
- Catalytic Domain -- genetics
- DNA Mutational Analysis
- Drug Resistance, Neoplasm -- genetics
- Female
- Fusion Proteins, bcr-abl -- chemistry
- Gene Frequency
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Malaysia -- epidemiology
- Male
- Middle Aged
- Mutation, Missense
- Piperazines -- therapeutic use
- Prognosis
- Protein Kinase Inhibitors -- therapeutic use
- Pyrimidines -- therapeutic use
- Survival Analysis
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.